首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking
【2h】

Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking

机译:基于基于复合物的药理团和分子对接的虚拟筛选方法的混合协议发现新型的黏着斑激酶抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Focal adhesion kinase (FAK) is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. In the current study, the multicomplex-based pharmacophore (MCBP)-guided method has been suggested to generate a comprehensive pharmacophore of FAK kinase based on seven crystal structures of FAK-inhibitor complexes. In this investigation, a hybrid protocol of virtual screening methods, comprising of pharmacophore model-based virtual screening (PB-VS) and docking-based virtual screening (DB-VS), is used for retrieving new FAK inhibitors from commercially available chemical databases. This hybrid virtual screening approach was then applied to screen several chemical databases, including the Specs (202,408 compounds) database. Thirty-five compounds were selected from the final hits and should be shifted to experimental studies. These results may provide important information for further research of novel FAK inhibitors.
机译:黏着斑激酶(FAK)是一种酪氨酸激酶,可作为导致入侵和转移的信号的关键协调器。在当前的研究中,基于多重复合物的药效团(MCBP)指导的方法已被建议基于FAK抑制剂复合物的七个晶体结构来生成FAK激酶的综合药效团。在这项研究中,虚拟筛选方法的混合协议,包括基于药效团模型的虚拟筛选(PB-VS)和基于对接的虚拟筛选(DB-VS),用于从市售化学数据库中检索新的FAK抑制剂。然后将此混合虚拟筛选方法应用于筛选几个化学数据库,包括“规格”(202,408种化合物)数据库。从最终结果中选择了35种化合物,应将其转移到实验研究中。这些结果可能为进一步研究新型FAK抑制剂提供重要信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号